Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List
| Dataset | w6a_vs_wt_vs_wt.w6a_vs_wt.cls #ago1w6a_versus_ago1gfp.w6a_vs_wt.cls #ago1w6a_versus_ago1gfp_repos |
| Phenotype | w6a_vs_wt.cls#ago1w6a_versus_ago1gfp_repos |
| Upregulated in class | ago1w6a |
| GeneSet | KEGG_FOCAL_ADHESION |
| Enrichment Score (ES) | 0.29900357 |
| Normalized Enrichment Score (NES) | 1.2884587 |
| Nominal p-value | 0.03236246 |
| FDR q-value | 0.33729795 |
| FWER p-Value | 0.999 |
| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | THBS1 | NA | THBS1 Entrez, Source | thrombospondin 1 | 81 | 3.120 | 0.0189 | Yes |
| 2 | LAMA4 | NA | LAMA4 Entrez, Source | laminin, alpha 4 | 103 | 2.927 | 0.0406 | Yes |
| 3 | COL5A3 | NA | COL5A3 Entrez, Source | collagen, type V, alpha 3 | 139 | 2.572 | 0.0585 | Yes |
| 4 | BIRC3 | NA | BIRC3 Entrez, Source | baculoviral IAP repeat-containing 3 | 152 | 2.495 | 0.0774 | Yes |
| 5 | ITGA10 | NA | ITGA10 Entrez, Source | integrin, alpha 10 | 164 | 2.415 | 0.0958 | Yes |
| 6 | ITGA2 | NA | ITGA2 Entrez, Source | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 192 | 2.266 | 0.1118 | Yes |
| 7 | PAK6 | NA | PAK6 Entrez, Source | p21(CDKN1A)-activated kinase 6 | 204 | 2.192 | 0.1285 | Yes |
| 8 | JUN | NA | JUN Entrez, Source | jun oncogene | 236 | 1.996 | 0.1420 | Yes |
| 9 | LAMC2 | NA | LAMC2 Entrez, Source | laminin, gamma 2 | 260 | 1.931 | 0.1557 | Yes |
| 10 | RAC2 | NA | RAC2 Entrez, Source | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 323 | 1.707 | 0.1647 | Yes |
| 11 | ITGB4 | NA | ITGB4 Entrez, Source | integrin, beta 4 | 327 | 1.696 | 0.1780 | Yes |
| 12 | ITGA5 | NA | ITGA5 Entrez, Source | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 390 | 1.519 | 0.1855 | Yes |
| 13 | MYL5 | NA | MYL5 Entrez, Source | myosin, light chain 5, regulatory | 404 | 1.496 | 0.1965 | Yes |
| 14 | TNXB | NA | TNXB Entrez, Source | tenascin XB | 415 | 1.484 | 0.2075 | Yes |
| 15 | MYLK2 | NA | MYLK2 Entrez, Source | myosin light chain kinase 2, skeletal muscle | 424 | 1.470 | 0.2186 | Yes |
| 16 | ITGB6 | NA | ITGB6 Entrez, Source | integrin, beta 6 | 456 | 1.396 | 0.2274 | Yes |
| 17 | CAPN2 | NA | CAPN2 Entrez, Source | calpain 2, (m/II) large subunit | 499 | 1.315 | 0.2348 | Yes |
| 18 | ACTG1 | NA | ACTG1 Entrez, Source | actin, gamma 1 | 583 | 1.201 | 0.2383 | Yes |
| 19 | ITGB8 | NA | ITGB8 Entrez, Source | integrin, beta 8 | 628 | 1.160 | 0.2443 | Yes |
| 20 | EGFR | NA | EGFR Entrez, Source | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 637 | 1.150 | 0.2528 | Yes |
| 21 | FLNA | NA | FLNA Entrez, Source | filamin A, alpha (actin binding protein 280) | 640 | 1.148 | 0.2618 | Yes |
| 22 | FLNB | NA | FLNB Entrez, Source | filamin B, beta (actin binding protein 278) | 700 | 1.099 | 0.2662 | Yes |
| 23 | BCAR1 | NA | BCAR1 Entrez, Source | breast cancer anti-estrogen resistance 1 | 761 | 1.040 | 0.2701 | Yes |
| 24 | ACTN1 | NA | ACTN1 Entrez, Source | actinin, alpha 1 | 849 | 0.978 | 0.2715 | Yes |
| 25 | VWF | NA | VWF Entrez, Source | von Willebrand factor | 919 | 0.933 | 0.2739 | Yes |
| 26 | ZYX | NA | ZYX Entrez, Source | zyxin | 960 | 0.916 | 0.2782 | Yes |
| 27 | ITGA3 | NA | ITGA3 Entrez, Source | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 1015 | 0.884 | 0.2813 | Yes |
| 28 | CCND1 | NA | CCND1 Entrez, Source | cyclin D1 | 1033 | 0.877 | 0.2870 | Yes |
| 29 | PXN | NA | PXN Entrez, Source | paxillin | 1118 | 0.844 | 0.2876 | Yes |
| 30 | ACTB | NA | ACTB Entrez, Source | actin, beta | 1127 | 0.840 | 0.2937 | Yes |
| 31 | ACTN4 | NA | ACTN4 Entrez, Source | actinin, alpha 4 | 1270 | 0.789 | 0.2895 | Yes |
| 32 | ITGA6 | NA | ITGA6 Entrez, Source | integrin, alpha 6 | 1327 | 0.764 | 0.2915 | Yes |
| 33 | VCL | NA | VCL Entrez, Source | vinculin | 1344 | 0.758 | 0.2964 | Yes |
| 34 | PRKCG | NA | PRKCG Entrez, Source | protein kinase C, gamma | 1414 | 0.740 | 0.2972 | Yes |
| 35 | SRC | NA | SRC Entrez, Source | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 1469 | 0.724 | 0.2990 | Yes |
| 36 | PIK3R1 | NA | PIK3R1 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) | 1699 | 0.658 | 0.2875 | No |
| 37 | MYLK | NA | MYLK Entrez, Source | myosin, light chain kinase | 1806 | 0.632 | 0.2847 | No |
| 38 | VAV1 | NA | VAV1 Entrez, Source | vav 1 oncogene | 1866 | 0.614 | 0.2853 | No |
| 39 | FLNC | NA | FLNC Entrez, Source | filamin C, gamma (actin binding protein 280) | 1962 | 0.594 | 0.2831 | No |
| 40 | BIRC2 | NA | BIRC2 Entrez, Source | baculoviral IAP repeat-containing 2 | 1964 | 0.594 | 0.2877 | No |
| 41 | COL6A1 | NA | COL6A1 Entrez, Source | collagen, type VI, alpha 1 | 2131 | 0.564 | 0.2800 | No |
| 42 | HRAS | NA | HRAS Entrez, Source | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 2253 | 0.541 | 0.2755 | No |
| 43 | COL4A2 | NA | COL4A2 Entrez, Source | collagen, type IV, alpha 2 | 2271 | 0.538 | 0.2785 | No |
| 44 | BRAF | NA | BRAF Entrez, Source | v-raf murine sarcoma viral oncogene homolog B1 | 2275 | 0.537 | 0.2826 | No |
| 45 | PAK2 | NA | PAK2 Entrez, Source | p21 (CDKN1A)-activated kinase 2 | 2276 | 0.537 | 0.2868 | No |
| 46 | COL4A1 | NA | COL4A1 Entrez, Source | collagen, type IV, alpha 1 | 2408 | 0.514 | 0.2813 | No |
| 47 | MAPK8 | NA | MAPK8 Entrez, Source | mitogen-activated protein kinase 8 | 2742 | 0.461 | 0.2606 | No |
| 48 | RASGRF1 | NA | RASGRF1 Entrez, Source | Ras protein-specific guanine nucleotide-releasing factor 1 | 2886 | 0.436 | 0.2536 | No |
| 49 | PIP5K1C | NA | PIP5K1C Entrez, Source | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | 3064 | 0.412 | 0.2439 | No |
| 50 | CAV1 | NA | CAV1 Entrez, Source | caveolin 1, caveolae protein, 22kDa | 3483 | 0.356 | 0.2162 | No |
| 51 | ITGA8 | NA | ITGA8 Entrez, Source | integrin, alpha 8 | 3756 | 0.327 | 0.1989 | No |
| 52 | MYL12A | NA | 3767 | 0.326 | 0.2007 | No | ||
| 53 | TLN2 | NA | TLN2 Entrez, Source | talin 2 | 3776 | 0.324 | 0.2027 | No |
| 54 | VAV2 | NA | VAV2 Entrez, Source | vav 2 oncogene | 3835 | 0.317 | 0.2010 | No |
| 55 | KDR | NA | KDR Entrez, Source | kinase insert domain receptor (a type III receptor tyrosine kinase) | 4101 | 0.287 | 0.1839 | No |
| 56 | PAK1 | NA | PAK1 Entrez, Source | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | 4258 | 0.271 | 0.1746 | No |
| 57 | PDGFA | NA | PDGFA Entrez, Source | platelet-derived growth factor alpha polypeptide | 4294 | 0.267 | 0.1742 | No |
| 58 | ROCK1 | NA | ROCK1 Entrez, Source | Rho-associated, coiled-coil containing protein kinase 1 | 4370 | 0.257 | 0.1707 | No |
| 59 | SHC3 | NA | SHC3 Entrez, Source | SHC (Src homology 2 domain containing) transforming protein 3 | 4443 | 0.250 | 0.1674 | No |
| 60 | TNC | NA | TNC Entrez, Source | tenascin C (hexabrachion) | 4457 | 0.248 | 0.1685 | No |
| 61 | DIAPH1 | NA | DIAPH1 Entrez, Source | diaphanous homolog 1 (Drosophila) | 4482 | 0.245 | 0.1687 | No |
| 62 | XIAP | NA | 4549 | 0.237 | 0.1657 | No | ||
| 63 | PPP1R12A | NA | PPP1R12A Entrez, Source | protein phosphatase 1, regulatory (inhibitor) subunit 12A | 4657 | 0.228 | 0.1597 | No |
| 64 | ROCK2 | NA | ROCK2 Entrez, Source | Rho-associated, coiled-coil containing protein kinase 2 | 4724 | 0.219 | 0.1566 | No |
| 65 | PAK4 | NA | PAK4 Entrez, Source | p21(CDKN1A)-activated kinase 4 | 4811 | 0.210 | 0.1520 | No |
| 66 | MAP2K1 | NA | MAP2K1 Entrez, Source | mitogen-activated protein kinase kinase 1 | 4894 | 0.202 | 0.1476 | No |
| 67 | VASP | NA | VASP Entrez, Source | vasodilator-stimulated phosphoprotein | 4950 | 0.197 | 0.1451 | No |
| 68 | COL2A1 | NA | COL2A1 Entrez, Source | collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) | 5037 | 0.188 | 0.1403 | No |
| 69 | MYL10 | NA | 5067 | 0.185 | 0.1397 | No | ||
| 70 | RAPGEF1 | NA | RAPGEF1 Entrez, Source | Rap guanine nucleotide exchange factor (GEF) 1 | 5186 | 0.172 | 0.1324 | No |
| 71 | PIK3CB | NA | PIK3CB Entrez, Source | phosphoinositide-3-kinase, catalytic, beta polypeptide | 5293 | 0.162 | 0.1259 | No |
| 72 | LAMA5 | NA | LAMA5 Entrez, Source | laminin, alpha 5 | 5549 | 0.134 | 0.1083 | No |
| 73 | RAC1 | NA | RAC1 Entrez, Source | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 5556 | 0.134 | 0.1090 | No |
| 74 | SHC4 | NA | SHC4 Entrez, Source | SHC (Src homology 2 domain containing) family, member 4 | 5583 | 0.130 | 0.1081 | No |
| 75 | ITGB7 | NA | ITGB7 Entrez, Source | integrin, beta 7 | 5713 | 0.115 | 0.0996 | No |
| 76 | CCND3 | NA | CCND3 Entrez, Source | cyclin D3 | 5722 | 0.114 | 0.0999 | No |
| 77 | COL11A1 | NA | COL11A1 Entrez, Source | collagen, type XI, alpha 1 | 5734 | 0.113 | 0.1000 | No |
| 78 | PPP1CC | NA | PPP1CC Entrez, Source | protein phosphatase 1, catalytic subunit, gamma isoform | 5761 | 0.111 | 0.0990 | No |
| 79 | ACTN2 | NA | ACTN2 Entrez, Source | actinin, alpha 2 | 5838 | 0.103 | 0.0942 | No |
| 80 | MET | NA | MET Entrez, Source | met proto-oncogene (hepatocyte growth factor receptor) | 5916 | 0.096 | 0.0893 | No |
| 81 | FN1 | NA | FN1 Entrez, Source | fibronectin 1 | 6142 | 0.073 | 0.0734 | No |
| 82 | CRKL | NA | CRKL Entrez, Source | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 6281 | 0.059 | 0.0638 | No |
| 83 | LAMB3 | NA | LAMB3 Entrez, Source | laminin, beta 3 | 6357 | 0.054 | 0.0588 | No |
| 84 | CRK | NA | CRK Entrez, Source | v-crk sarcoma virus CT10 oncogene homolog (avian) | 6376 | 0.051 | 0.0578 | No |
| 85 | LAMA2 | NA | LAMA2 Entrez, Source | laminin, alpha 2 (merosin, congenital muscular dystrophy) | 6420 | 0.047 | 0.0551 | No |
| 86 | COL5A1 | NA | COL5A1 Entrez, Source | collagen, type V, alpha 1 | 6499 | 0.039 | 0.0497 | No |
| 87 | ELK1 | NA | ELK1 Entrez, Source | ELK1, member of ETS oncogene family | 6756 | 0.012 | 0.0310 | No |
| 88 | PDPK1 | NA | PDPK1 Entrez, Source | 3-phosphoinositide dependent protein kinase-1 | 6775 | 0.009 | 0.0298 | No |
| 89 | LAMC1 | NA | LAMC1 Entrez, Source | laminin, gamma 1 (formerly LAMB2) | 6862 | 0.001 | 0.0235 | No |
| 90 | LAMB1 | NA | LAMB1 Entrez, Source | laminin, beta 1 | 6938 | -0.008 | 0.0181 | No |
| 91 | PTEN | NA | PTEN Entrez, Source | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 6985 | -0.013 | 0.0148 | No |
| 92 | ITGAV | NA | ITGAV Entrez, Source | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 7059 | -0.019 | 0.0096 | No |
| 93 | AKT2 | NA | AKT2 Entrez, Source | v-akt murine thymoma viral oncogene homolog 2 | 7140 | -0.027 | 0.0040 | No |
| 94 | LAMA1 | NA | LAMA1 Entrez, Source | laminin, alpha 1 | 7314 | -0.046 | -0.0083 | No |
| 95 | SOS1 | NA | SOS1 Entrez, Source | son of sevenless homolog 1 (Drosophila) | 7393 | -0.055 | -0.0136 | No |
| 96 | ARHGAP5 | NA | ARHGAP5 Entrez, Source | Rho GTPase activating protein 5 | 7510 | -0.067 | -0.0215 | No |
| 97 | SHC1 | NA | SHC1 Entrez, Source | SHC (Src homology 2 domain containing) transforming protein 1 | 7588 | -0.074 | -0.0266 | No |
| 98 | ITGB3 | NA | ITGB3 Entrez, Source | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 7628 | -0.078 | -0.0288 | No |
| 99 | CDC42 | NA | CDC42 Entrez, Source | cell division cycle 42 (GTP binding protein, 25kDa) | 7674 | -0.082 | -0.0315 | No |
| 100 | CAV2 | NA | CAV2 Entrez, Source | caveolin 2 | 7705 | -0.084 | -0.0330 | No |
| 101 | VEGFA | NA | 7811 | -0.096 | -0.0399 | No | ||
| 102 | COL6A3 | NA | COL6A3 Entrez, Source | collagen, type VI, alpha 3 | 7823 | -0.097 | -0.0400 | No |
| 103 | ITGB5 | NA | ITGB5 Entrez, Source | integrin, beta 5 | 7873 | -0.102 | -0.0427 | No |
| 104 | RHOA | NA | RHOA Entrez, Source | ras homolog gene family, member A | 8007 | -0.115 | -0.0516 | No |
| 105 | PPP1CB | NA | PPP1CB Entrez, Source | protein phosphatase 1, catalytic subunit, beta isoform | 8008 | -0.115 | -0.0506 | No |
| 106 | PTK2 | NA | PTK2 Entrez, Source | PTK2 protein tyrosine kinase 2 | 8268 | -0.144 | -0.0685 | No |
| 107 | RAP1B | NA | RAP1B Entrez, Source | RAP1B, member of RAS oncogene family | 8297 | -0.146 | -0.0693 | No |
| 108 | TLN1 | NA | TLN1 Entrez, Source | talin 1 | 8348 | -0.151 | -0.0718 | No |
| 109 | DOCK1 | NA | DOCK1 Entrez, Source | dedicator of cytokinesis 1 | 8352 | -0.152 | -0.0708 | No |
| 110 | RAP1A | NA | RAP1A Entrez, Source | RAP1A, member of RAS oncogene family | 8399 | -0.157 | -0.0729 | No |
| 111 | PIK3R3 | NA | PIK3R3 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) | 8472 | -0.166 | -0.0769 | No |
| 112 | MYL12B | NA | 8537 | -0.172 | -0.0802 | No | ||
| 113 | GRB2 | NA | GRB2 Entrez, Source | growth factor receptor-bound protein 2 | 8662 | -0.186 | -0.0878 | No |
| 114 | IGF1R | NA | IGF1R Entrez, Source | insulin-like growth factor 1 receptor | 8663 | -0.186 | -0.0863 | No |
| 115 | PPP1CA | NA | PPP1CA Entrez, Source | protein phosphatase 1, catalytic subunit, alpha isoform | 8679 | -0.188 | -0.0859 | No |
| 116 | ILK | NA | ILK Entrez, Source | integrin-linked kinase | 8729 | -0.194 | -0.0880 | No |
| 117 | GSK3B | NA | GSK3B Entrez, Source | glycogen synthase kinase 3 beta | 8844 | -0.207 | -0.0947 | No |
| 118 | FLT1 | NA | FLT1 Entrez, Source | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 8910 | -0.215 | -0.0977 | No |
| 119 | CCND2 | NA | CCND2 Entrez, Source | cyclin D2 | 8965 | -0.222 | -0.0999 | No |
| 120 | MAPK1 | NA | MAPK1 Entrez, Source | mitogen-activated protein kinase 1 | 8973 | -0.222 | -0.0986 | No |
| 121 | BAD | NA | BAD Entrez, Source | BCL2-antagonist of cell death | 9149 | -0.244 | -0.1095 | No |
| 122 | COL4A6 | NA | COL4A6 Entrez, Source | collagen, type IV, alpha 6 | 9256 | -0.258 | -0.1152 | No |
| 123 | THBS4 | NA | THBS4 Entrez, Source | thrombospondin 4 | 9288 | -0.261 | -0.1154 | No |
| 124 | LAMC3 | NA | LAMC3 Entrez, Source | laminin, gamma 3 | 9430 | -0.283 | -0.1235 | No |
| 125 | RAF1 | NA | RAF1 Entrez, Source | v-raf-1 murine leukemia viral oncogene homolog 1 | 9437 | -0.284 | -0.1217 | No |
| 126 | MYLPF | NA | MYLPF Entrez, Source | - | 9486 | -0.292 | -0.1228 | No |
| 127 | TNN | NA | TNN Entrez, Source | tenascin N | 9624 | -0.310 | -0.1304 | No |
| 128 | ARHGAP35 | NA | 9687 | -0.319 | -0.1324 | No | ||
| 129 | PIK3CA | NA | PIK3CA Entrez, Source | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 9727 | -0.326 | -0.1327 | No |
| 130 | MAPK9 | NA | MAPK9 Entrez, Source | mitogen-activated protein kinase 9 | 9823 | -0.340 | -0.1369 | No |
| 131 | ERBB2 | NA | ERBB2 Entrez, Source | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 9967 | -0.359 | -0.1445 | No |
| 132 | AKT1 | NA | AKT1 Entrez, Source | v-akt murine thymoma viral oncogene homolog 1 | 10063 | -0.374 | -0.1485 | No |
| 133 | MAPK10 | NA | MAPK10 Entrez, Source | mitogen-activated protein kinase 10 | 10142 | -0.384 | -0.1512 | No |
| 134 | PARVB | NA | PARVB Entrez, Source | parvin, beta | 10163 | -0.388 | -0.1496 | No |
| 135 | ITGB1 | NA | ITGB1 Entrez, Source | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 10722 | -0.479 | -0.1866 | No |
| 136 | BCL2 | NA | BCL2 Entrez, Source | B-cell CLL/lymphoma 2 | 10892 | -0.508 | -0.1949 | No |
| 137 | PIK3R2 | NA | PIK3R2 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta) | 11136 | -0.552 | -0.2083 | No |
| 138 | PARVG | NA | PARVG Entrez, Source | parvin, gamma | 11209 | -0.565 | -0.2091 | No |
| 139 | IGF1 | NA | IGF1 Entrez, Source | insulin-like growth factor 1 (somatomedin C) | 11398 | -0.605 | -0.2181 | No |
| 140 | EGF | NA | EGF Entrez, Source | epidermal growth factor (beta-urogastrone) | 11460 | -0.616 | -0.2176 | No |
| 141 | PDGFC | NA | PDGFC Entrez, Source | platelet derived growth factor C | 11490 | -0.622 | -0.2148 | No |
| 142 | COL11A2 | NA | COL11A2 Entrez, Source | collagen, type XI, alpha 2 | 11979 | -0.746 | -0.2446 | No |
| 143 | ITGA1 | NA | ITGA1 Entrez, Source | integrin, alpha 1 | 11982 | -0.747 | -0.2388 | No |
| 144 | CTNNB1 | NA | CTNNB1 Entrez, Source | catenin (cadherin-associated protein), beta 1, 88kDa | 12021 | -0.762 | -0.2355 | No |
| 145 | PRKCA | NA | PRKCA Entrez, Source | protein kinase C, alpha | 12193 | -0.818 | -0.2415 | No |
| 146 | PDGFRA | NA | PDGFRA Entrez, Source | platelet-derived growth factor receptor, alpha polypeptide | 12202 | -0.819 | -0.2356 | No |
| 147 | VAV3 | NA | VAV3 Entrez, Source | vav 3 oncogene | 12323 | -0.863 | -0.2375 | No |
| 148 | COL6A6 | NA | 12346 | -0.872 | -0.2322 | No | ||
| 149 | VEGFB | NA | VEGFB Entrez, Source | vascular endothelial growth factor B | 12361 | -0.878 | -0.2263 | No |
| 150 | ITGA7 | NA | ITGA7 Entrez, Source | integrin, alpha 7 | 12379 | -0.885 | -0.2205 | No |
| 151 | CHAD | NA | CHAD Entrez, Source | chondroadherin | 12380 | -0.886 | -0.2134 | No |
| 152 | PDGFB | NA | PDGFB Entrez, Source | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 12572 | -0.972 | -0.2197 | No |
| 153 | PARVA | NA | PARVA Entrez, Source | parvin, alpha | 12599 | -0.981 | -0.2138 | No |
| 154 | COL5A2 | NA | COL5A2 Entrez, Source | collagen, type V, alpha 2 | 12707 | -1.040 | -0.2134 | No |
| 155 | SOS2 | NA | SOS2 Entrez, Source | son of sevenless homolog 2 (Drosophila) | 12762 | -1.068 | -0.2088 | No |
| 156 | THBS3 | NA | THBS3 Entrez, Source | thrombospondin 3 | 12840 | -1.116 | -0.2056 | No |
| 157 | FYN | NA | FYN Entrez, Source | FYN oncogene related to SRC, FGR, YES | 13049 | -1.256 | -0.2108 | No |
| 158 | LAMA3 | NA | LAMA3 Entrez, Source | laminin, alpha 3 | 13132 | -1.319 | -0.2064 | No |
| 159 | RAC3 | NA | RAC3 Entrez, Source | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 13155 | -1.344 | -0.1973 | No |
| 160 | PIK3CG | NA | PIK3CG Entrez, Source | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 13175 | -1.371 | -0.1878 | No |
| 161 | MAPK3 | NA | MAPK3 Entrez, Source | mitogen-activated protein kinase 3 | 13226 | -1.426 | -0.1801 | No |
| 162 | PDGFRB | NA | PDGFRB Entrez, Source | platelet-derived growth factor receptor, beta polypeptide | 13337 | -1.562 | -0.1757 | No |
| 163 | LAMB2 | NA | LAMB2 Entrez, Source | laminin, beta 2 (laminin S) | 13365 | -1.595 | -0.1650 | No |
| 164 | AKT3 | NA | AKT3 Entrez, Source | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 13407 | -1.667 | -0.1548 | No |
| 165 | COL4A4 | NA | COL4A4 Entrez, Source | collagen, type IV, alpha 4 | 13626 | -2.159 | -0.1536 | No |
| 166 | PRKCB | NA | 13643 | -2.224 | -0.1371 | No | ||
| 167 | MYLK3 | NA | 13665 | -2.307 | -0.1203 | No | ||
| 168 | COL1A1 | NA | COL1A1 Entrez, Source | collagen, type I, alpha 1 | 13723 | -2.670 | -0.1032 | No |
| 169 | PIK3CD | NA | PIK3CD Entrez, Source | phosphoinositide-3-kinase, catalytic, delta polypeptide | 13763 | -3.033 | -0.0820 | No |
| 170 | VTN | NA | VTN Entrez, Source | vitronectin | 13776 | -3.164 | -0.0577 | No |
| 171 | COL3A1 | NA | COL3A1 Entrez, Source | collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) | 13796 | -3.638 | -0.0302 | No |
| 172 | ITGA2B | NA | ITGA2B Entrez, Source | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 13815 | -4.140 | 0.0014 | No |
